Bcl-2 antisense oligonucleotides enhance the cytotoxicity of chlorambucil in B-cell chronic lymphocytic leukaemia cells

Leukemia and Lymphoma

Volumn 42, Issue 3, 2001, Pages 491-498

  Pepper, C ^a   Hooper, K ^a   Thomas, A ^a   Hoy, T ^a   Bentley, P ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

Author keywords

Antisense oligonucleotides cytotoxicity; B cell CLL; Bcl 2; Chlorambucil; Chronic lymphocytic leukaemia

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CHLORAMBUCIL; ODN 2009; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG;

ARTICLE; B CELL LEUKEMIA; CELL DEATH; CHEMOSENSITIVITY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; DRUG SENSITIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; LEUKEMIA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034898772     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428190109064606     Document Type: Article

References (18)

1. Molecular biology of chronic lymphocytic leukemia: Implications for therapy
2. Bcl-2 gene hypomethylation and high level expression in B-cell chronic lymphocytic leukemia
3. Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome
4. Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukaemia
5. Bcl-2, bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression
6. Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance
7. Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2-expressing subclones
8. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: Comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides
9. Investigations of antisense oligonucleotides targeted against bcl-2 RNAs
10. Antisense oligonucleotides suppress B-cell lymphoma growth in SCID-humouse model
11. Bcl-2 antisense therapy in patients with non-Hodgkin lymphoma
12. Antisense-mediated suppression of Bcl-2 highlights its pivotal role in failed apoptosis in B-cell chronic lymphocytic leukaemia
13. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis
14. Induction of apoptosis in small-cell lung cancer cells by an antisense oligonucleotide targeting the Bcl-2 coding sequence
15. Flow cytometric analysis of the early phases of apoptosis by cellular and nuclear techniques
16. A novel assay for apoptosis: Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V
17. Bcl-2 heterodimerizes in vitro with a conserved homolog, bax, that accelerates programmed cell death
18. Elevated Bcl-2/Bax are a consistent feature of apoptosis resistance in B-cell chronic lymphocytic leukaemia and are correlated with in vivo chemoresistance